ArticleBritish journal of cancer2020

FKBPL-based peptide, ALM201, targets angiogenesis and cancer stem cells in ovarian cancer.

Stephanie Annett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.